Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 31.08%240.46M | 16.93%191.63M | 19.41%711.24M | 6.44%182.53M | 26.23%181.38M | 26.94%183.44M | 20.54%163.88M | -1.47%595.64M | 26.75%171.49M | -11.10%143.69M |
| Cost of revenue | 19.21%165.49M | 1.95%135.45M | 11.56%539.25M | 3.02%139.88M | 15.75%127.48M | 20.25%138.82M | 8.86%132.85M | -2.47%483.39M | 6.62%135.78M | -16.95%110.14M |
| Gross profit | 68.00%74.97M | 81.04%56.18M | 53.22%171.99M | 19.46%42.66M | 60.65%53.91M | 53.52%44.63M | 122.93%31.03M | 3.12%112.25M | 349.47%35.71M | 15.62%33.56M |
| Operating expense | -1.83%6.07M | 12.31%7.61M | 0.93%26.59M | 3.52%7.7M | -10.77%5.54M | 2.27%6.18M | 1.94%6.78M | 7.65%26.35M | 11.21%7.44M | 11.07%6.21M |
| Selling and administrative expenses | -1.83%6.07M | 12.31%7.61M | 0.93%26.59M | 3.52%7.7M | -10.77%5.54M | 2.27%6.18M | 1.94%6.78M | 7.65%26.35M | 11.21%7.44M | 11.07%6.21M |
| -General and administrative expense | -1.83%6.07M | 12.31%7.61M | 0.93%26.59M | 3.52%7.7M | -10.77%5.54M | 2.27%6.18M | 1.94%6.78M | 7.65%26.35M | 11.21%7.44M | 11.07%6.21M |
| Operating profit | 79.23%68.9M | 100.25%48.57M | 69.26%145.4M | 23.66%34.95M | 76.87%48.37M | 66.99%38.44M | 233.54%24.26M | 1.80%85.9M | 2,155.79%28.27M | 16.71%27.35M |
| Net non-operating interest income (expenses) | 66.91%-582K | 61.00%-782K | 85.97%-965K | 35.66%-1.33M | 28.06%-1.55M | 19.94%-1.76M | 8.66%-2.01M | -33.52%-6.88M | -1,058.60%-2.06M | -4.36%-2.16M |
| Non-operating interest income | ---- | ---- | 228.09%5.68M | ---- | ---- | ---- | ---- | -26.94%1.73M | ---- | ---- |
| Non-operating interest expense | -66.91%582K | -61.00%782K | -22.86%6.64M | -35.66%1.33M | -28.06%1.55M | -19.94%1.76M | -8.66%2.01M | 14.48%8.61M | -4.27%2.06M | 4.36%2.16M |
| Net investment income | -71.04%-22.89M | -886.13%-13.38M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 96.28%2.69M | 36.42%1.37M | ||||||||
| Income from associates and other participating interests | -17.02%39K | 57K | 57K | 36K | -26K | 47K | 0 | 0 | 0 | 0 |
| Special income (charges) | -168.63%-105K | -70.80%153K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | -21.67%253K | ---- | ---- | ---- | ---- | 108.62%323K | ---- | ---- |
| Less:Other special charges | ---- | ---- | 68.91%-148K | ---- | ---- | ---- | ---- | -37.18%-476K | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | -123.94%-1.36M | 182.26%3.68M | -9.65%6.69M | -100.32%-4.4M | -503.99%-4.76M | 1,111.57%5.69M | -291.17%-4.48M | 3,184.17%7.4M | -125.23%-2.2M | 117.52%1.18M |
| Income before tax | 57.95%67M | 189.88%51.53M | 75.51%130.88M | 21.89%29.27M | 59.42%42.03M | 109.33%42.42M | 351.95%17.78M | -9.30%74.57M | 79.17%24.01M | 80.03%26.37M |
| Income tax | 4.37%12.52M | 92.88%12.92M | 34.08%35.94M | -49.25%5.3M | 59.87%11.96M | 73.64%11.99M | 238.75%6.7M | 0.39%26.8M | 88.77%10.44M | 50.32%7.48M |
| Net income | 79.07%54.48M | 248.52%38.61M | 98.76%94.94M | 76.62%23.97M | 59.24%30.08M | 127.79%30.42M | 466.36%11.08M | -13.96%47.77M | 72.43%13.57M | 95.33%18.89M |
| Net income continuous operations | 79.07%54.48M | 248.52%38.61M | 98.76%94.94M | 76.62%23.97M | 59.24%30.08M | 127.79%30.42M | 466.36%11.08M | -13.96%47.77M | 72.43%13.57M | 95.33%18.89M |
| Noncontrolling interests | -78.96%-893K | 138.49%851K | 43.99%-1.5M | 115.03%227K | 1,395.18%1.08M | -35.97%-499K | -207.08%-2.21M | 53.83%-2.68M | -106.28%-1.51M | 97.27%-83K |
| Net income attributable to the company | 79.07%55.37M | 184.13%37.76M | 91.17%96.44M | 57.43%23.74M | 52.88%29M | 125.34%30.92M | 396.60%13.29M | -17.74%50.45M | 75.31%15.08M | 49.22%18.97M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 79.07%55.37M | 184.13%37.76M | 91.17%96.44M | 57.43%23.74M | 52.88%29M | 125.34%30.92M | 396.60%13.29M | -17.74%50.45M | 75.31%15.08M | 49.22%18.97M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 79.10%0.264 | 183.91%0.18 | 91.19%0.4598 | 57.44%0.1132 | 52.88%0.1382 | 125.38%0.1474 | 395.31%0.0634 | -17.75%0.2405 | 74.94%0.0719 | 49.17%0.0904 |
| Diluted earnings per share | 79.10%0.264 | 183.91%0.18 | 91.19%0.4598 | 57.44%0.1132 | 52.88%0.1382 | 125.38%0.1474 | 395.31%0.0634 | -17.75%0.2405 | 74.94%0.0719 | 49.17%0.0904 |
| Dividend per share | 0 | 0.00%0.07 | 0.00%0.12 | 0 | 0.00%0.05 | 0 | 0.00%0.07 | 20.00%0.12 | 0 | 0.00%0.05 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.